“The development of HMOs is a breakthrough in the nutritional improvement of infant formulas. BASF's Newtrition brand has developed a baby formula that the maker said has been found to help in the development of a healthy gut microbiome and immune system. The 2'-fucosyllactose (2'-FL), a human milk oligosaccharide (HMO) can also protect against allergic diseases and aid the development of brain functions, the company said. Although there is no substitute for natural breast milk, 2'-FL is a substantial step closer to it than other breast milk substitutes, BASF said. In addition to its new product, BASF will launch two more products this year aimed at improving infant nutrition with an emphasis on breastfeeding.
BASF's Newtrition brand has developed a baby formula that the maker said has been found to help in the development of a healthy gut microbiome and immune system. The 2'-fucosyllactose (2'-FL), a human milk oligosaccharide (HMO) can also protect against allergic diseases and aid the development of brain functions, the company said. Although there is no substitute for natural breast milk, 2'-FL is a substantial step closer to it than other breast milk substitutes, BASF said. In addition to its new product, BASF will launch two more products this year aimed at improving infant nutrition with an emphasis on breastfeeding.